IPA punches holes into drug pricing policy implementation
Pharma companies have become a victim of "unbridled turf war" between the Department of Pharma and drug price regulator NPPA.

Pharma companies have become a victim of "unbridled turf war" between the Department of Pharma and drug price regulator NPPA.
The draft National Commission for Indian Systems of Medicine (NCISM) Bill, 2017 will cover Ayurveda, Unani, Siddha and Sowa-Rigpa, Yoga and Naturopathy.
The committee chaired by NITI Aayog vice chairman Arvind Panagariya has proposed that the Indian Medicine Central Council (IMCC) Act, 1970 and Homoeopathy Central Council (HCC) Act, 1973 be replaced by two new Acts.
Indian pharma lobby wants the commerce ministry, India's mission in Washington and New York to proactively engage with the Trump administration and lobby the Capitol Hill to seek policy changes that would favour Indian drug companies.
National Medical Commission will become the main regulatory body and will take over all roles and responsibilities of MCI.
After having focused on reforming the controversy-hit Medical Council of India, the government is scrutinising the functioning of regulatory bodies governing Indian medicine and homeopathy.
The bill, if it goes through, would end the much-criticised inspector raj, presenting a major reform of the medical education system and the profession.
"The committee on MCI has finalised its report after several rounds of deliberation on the issue with stakeholders and experts," a source said.